BioCryst Pharmaceuticals, Inc. (BCRX)

7.70 +0.17 (+2.26%) USD  |  NASDAQ  |  Dec 24, 16:00
More

BioCryst Pharmaceuticals EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Astria Therapeutics, Inc. Upgrade
Hologic, Inc. Upgrade
Johnson & Johnson Upgrade
Viatris, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade